Merrion Investment Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ATO
Merrion Investment Management's ABBV Position: Q2 2026 in Review
Merrion Investment Management held its AbbVie (ABBV) position steady in Q2 2026 at 7,000 shares worth $1.76M. The position accounts for 0.83% of the portfolio, ranked #28.
Merrion Investment Management first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. 1,757 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Merrion Investment Management held 7,000 shares of AbbVie worth $1.76M as of Q2 2026.
- Merrion Investment Management left its AbbVie share count unchanged in Q2 2026.
- AbbVie made up 0.83% of Merrion Investment Management's portfolio in Q2 2026, its #28 holding.
- Merrion Investment Management first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
- 1,757 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Merrion Investment Management's 13F filing for Q2 2026, filed 13 Jul 2026.